FLADRICH MARK
GRUNENTHAL PHARMA SA Apoderado mancomunado
Their most recent appointment in the BORME is on 10 de September de 2019, in Apoderado mancomunado, where they hold the position of GRUNENTHAL PHARMA SA.
On September de 2019 they were appointed as Consejero of this company.
Their appointment as Presidente of this company was published on 10 de September de 2019.
They left their position of Consejero of this company in September de 2019.
Fladrich Mark left the position of Presidente in September de 2019.
This company has its headquarters in Madrid and undertakes its business in the wholesale of pharmaceutical products... sector.
/ without VAT
- Executive summary
- Position and company details